ASP6981

ASP6981 · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP6981, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia [Phase 1]

See pricing